- Will Seccombe, founder and co-creator of HealthTab, is returning to Avricore Health as its Communications Advisor
- His responsibilities will include leading the marketing of initiatives such as the HealthTab system to consumers and investors
- Avricore has also granted 1,800,000 stock options to certain consultants, directors, and officers of the company
- Avricore Health’s (AVCR) goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health
- Avricore Health Inc. (AVCR) opened trading on the TSXV at C$0.235 per share
Will Seccombe, founder and co-creator of HealthTab, is returning to Avricore Health as its Communications Advisor.
Mr. Seccombe will lead the company in the development of marketing initiatives, including HealthTab brand messaging.
Other responsibilities of the position include developing in-store communications and identifying opportunities for marketing to investors.
Mr. Seccombe has 18 years of experience in creating strategic messaging and design systems that align with Avricore’s values and resonate with all stakeholders.
Avricore Health CEO Hector Bremner commented on the return of Mr. Seccombe to the company.
“Will brings a deep understanding of the HealthTab product and is committed to its long-term success as a tool for tackling chronic disease,” he said. “We look forward to having his insight and expertise as we move into our next chapter of growth.”
Avricore has also granted 1,800,000 stock options to certain consultants, directors, and officers of the company to purchase common shares at C$0.25 per share for a period of five years.
Avricore Health’s (AVCR) goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.
HealthTab is a point-of-care screening system that was created to support pharmacists by allowing patients to be proactive about their health. The system offers real-time evaluations by measuring and monitoring key safety tests and biomarkers of chronic disease.
Avricore Health Inc. (AVCR) opened trading on the TSXV at C$0.235 per share.